Arch Fam Med
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 3 No. 12, December 1994 TABLE OF CONTENTS
 • Online Features
  Clinical Reviews
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Combination Antidepressant Therapy in Primary Care

Dana E. King, MD; Douglas H. Finestone, MD; James G. Peden, MD

Arch Fam Med. 1994;3(12):1088-1092.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Grimsley SR, Jann MW. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors. Clin Pharm. 1992;11:930-957. PUBMED
2. Caley CF, Weber SS. Paroxetine: a selective serotonin reuptake inhibiting antidepressant. Ann Pharmacother. 1993;27:1212-1222. ABSTRACT
3. Calabrese JR, Markovitz PJ. Treatment of depression: new pharmacologic approaches. Primary Care. 1991;18:421-433. PUBMED
4. Zarifan E, Rigal F. New antidepressants and trends in the pharmacotherapy of depressive disorders. Psychiatry Clin North Am. 1982;6:129-139.
5. Combining the antidepressant drugs. Lancet. 1965;2:118. Editorial.
6. Gander DR. Treatment of depressive illnesses with combined antidepressants. Lancet. 1965;2:107-109.
7. Sargant W. Combining the antidepressant drugs. Lancet. 1963;2:634-635. PUBMED
8. Zajecka JM, Jawcett J. Antidepressant combination and potentiation. Psychiatric Med. 1991;9:55-75.
9. Nierenberg AA, White K. What next? a review of pharmacologic strategies for treatment-resistant depression. Psychopharmacol Bull. 1990;26:429-460. PUBMED
10. Jacobsen FM. Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study. J Clin Psychiatry. 1990;51:298-302. PUBMED
11. Nierenberg AA, Keck PE. Management of monoamine oxidase inhibitor-associated insomnia with trazodone. J Clin Psychopharmacol. 1989;9:42-45. PUBMED
12. Nierenberg AA, Cole JO, Glass L. Possible trazodone potentiation of fluoxetine: a case series. J Clin Psychiatry. 1992;53:83-85. PUBMED
13. Weilburg JB, Rosenbaum JF, Meltzer-Brody S, Shushtari J. Tricyclic augmentation of fluoxetine. Ann Clin Psychiatry. 1991;3:209-213.
14. Nelson JC, Mazure CM, Bowers MB, Jatlow PI. A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression. Arch Gen Psychiatry. 1991;48:303-307. FREE FULL TEXT
15. Rosenthal JS, Kaswan MJ, Hemlock C, Winston A. Fluoxetine enhancement of heterocyclic antidepressants. In: Amsterdam JD, ed. Advances in Neuropsychiatry and Psychopharmacology. New York, NY: Raven Press Ltd; 1991;2:105-108.
16. Weilburg JB, Rosenbaum JF, Beiderman J, Sachs GS, Pollack MH, Kelly K. Fluoxetine added to non-MAOI antidepressants converts nonresponders to responders: a preliminary report. J Clin Psychiatry. 1989;50:447-449. PUBMED
17. Eisen A. Fluoxetine and desipramine: a strategy for augmenting antidepressant response. Pharmacopsychiatry. 1989;22:272-273. PUBMED
18. Lydiard RB, Anton RF, Cunningham T. Interactions between sertraline and tricyclic antidepressants. Am J Psychiatry. 1993;150:1125-1126. PUBMED
19. Gerner R. Rational polydrug use in psychiatry. West J Med. 1991;155:518. PUBMED
20. Baron BM, Ogden AM, Seigel BW, Stegeman J, Ursillo RC, Dudley MW. Rapid down regulation of β-adrenoceptors by co-administration of desipramine and fluoxetine. Eur J Pharmacol. 1988;154:125-134. PUBMED
21. Levin GM, DeVane CL. Prescribing attitudes of different physician groups regarding fluoxetine. Ann Pharmacother. 1993;27:1443-1447. ABSTRACT
22. Weinberger MH. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white, mild to moderate hypertensive patients. J Cardiovasc Pharmacol. 1985;7(suppl_1):S52-S55.
23. Extein IL. Recent fluoxetine treatment and complications of tricyclic therapy. Am J Psychiatry. 1991;148:1601-1602. PUBMED
24. Westermeyer J. Fluoxetine-induced tricyclic toxicity: extent and duration. J Clin Pharmacol. 1991;31:388-392. ABSTRACT
25. Cavanaugh SA. Drug-drug interactions of fluoxetine with tricyclics. Psychosomatics. 1990;31:273-276. PUBMED
26. Preskorn SH, Beber JH, Faul JC, Hirschfeld RMA. Serious adverse effects of combining fluoxetine and tricyclic antidepressants. Am J Psychiatry. 1990;147:532. PUBMED
27. Schraml F, Benedetti G, Hoyle K, Clayton A. Fluoxetine and nortriptyline combination therapy. Am J Psychiatry. 1989;146:1636-1637. PUBMED
28. Aranow RB, Hudson JI, Pope HG, et al. Elevated antidepressant plasma levels after addition of fluoxetine. Am J Psychiatry. 1989;146:911-913. PUBMED
29. Downs JM, Downs AD, Rosenthal TL, Deal N, Akiskal HS. Increased plasma tricyclic antidepressant concentrations in two patients concurrently treated with fluoxetine. J Clin Psychiatry. 1989;50:226-227. PUBMED
30. Goodnick PJ. Influence of fluoxetine on plasma levels of desipramine. Am J Psychiatry. 1989;146:552. PUBMED
31. Bell IR, Cole JO. Fluoxetine induces elevation of desipramine level and exacerbation of geriatric nonpsychotic depression. J Clin Psychopharmacol. 1988;8:447-448. PUBMED
32. Vaughan DA. Interaction of fluoxetine with tricyclic antidepressants. Am J Psychiatry. 1988;145:1478. PUBMED
33. Barros J, Asnis G. An interaction of sertraline and desipramine. Am J Psychiatry. 1993;150:1751. PUBMED
34. Spina E. Campo GM, Avenoso A, Pollicino MA, Caputi AP. Interaction between fluvoxamine and imipramine/desipramine in four patients. Ther Drug Monit. 1992;14:194-196. PUBMED
35. Bertschy G, Vandel S, Vandel B, Allers G, Volmat R. Fluvoxamine-tricyclic antidepressant interaction. Eur J Clin Pharmacol. 1991;40:119-120. PUBMED
36. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991;148:705-713. PUBMED
37. Depression Guideline Panel. Clinical Practice Guideline Number 5: Depression in Primary Care. Rockville, Md: Agency for Health Care Policy and Research; 1993;2. US Dept of Health and Human Services publication 93-0551.